Cyclic fasting bolsters cholesterol biosynthesis inhibitors’ anticancer activityA. Khalifa(Ospedale Policlinico San Martino), Alessio Nencioni(Ospedale Policlinico San Martino)Nature CommunicationsOctober 31, 202310.1038/s41467-023-42652-1Cited by 10SaveCiteExport RISWatch citationsRelated PapersFasting-mimicking diet and hormone therapy induce breast cancer regression|Nature|2020|355Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation|Blood|2006|132Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition|Oncotarget|2015|91Synergistic Interactions between HDAC and Sirtuin Inhibitors in Human Leukemia Cells|PLoS ONE|2011|86Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice|Thrombosis and Haemostasis|2013|50